Literature DB >> 24179598

Advances in homology directed genetic engineering of human pluripotent and adult stem cells.

Kalpith Ramamoorthi1, Donald Curtis, Prashanth Asuri.   

Abstract

The ability to introduce precise genomic modifications in human cells has profound implications for both basic and applied research in stem cells, ranging from identification of genes regulating stem cell self-renewal and multilineage differentiation to therapeutic gene correction and creation of in vitro models of human diseases. However, the overall efficiency of this process is challenged by several factors including inefficient gene delivery into stem cells and low rates of homology directed site-specific targeting. Recent studies report the development of novel techniques to improve gene targeting efficiencies in human stem cells; these methods include molecular engineering of viral vectors to efficiently deliver episomal genetic sequences that can participate in homology directed targeting, as well as the design of synthetic proteins that can introduce double-stranded breaks in DNA to initiate such recombination events. This review focuses on the potential of these new technologies to precisely alter the human stem cell genome and also highlights the possibilities offered by the combination of these complementary strategies.

Entities:  

Keywords:  Engineered viruses; Genetic engineering; Human stem cells; Synthetic restriction endonucleases

Year:  2013        PMID: 24179598      PMCID: PMC3812527          DOI: 10.4252/wjsc.v5.i4.98

Source DB:  PubMed          Journal:  World J Stem Cells        ISSN: 1948-0210            Impact factor:   5.326


  56 in total

Review 1.  Directed evolution of novel adeno-associated viruses for therapeutic gene delivery.

Authors:  M A Bartel; J R Weinstein; D V Schaffer
Journal:  Gene Ther       Date:  2012-03-08       Impact factor: 5.250

2.  Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer.

Authors:  Armin Blesch
Journal:  Methods       Date:  2004-06       Impact factor: 3.608

3.  Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations.

Authors:  Frank Soldner; Josée Laganière; Albert W Cheng; Dirk Hockemeyer; Qing Gao; Raaji Alagappan; Vikram Khurana; Lawrence I Golbe; Richard H Myers; Susan Lindquist; Lei Zhang; Dmitry Guschin; Lauren K Fong; B Joseph Vu; Xiangdong Meng; Fyodor D Urnov; Edward J Rebar; Philip D Gregory; H Steve Zhang; Rudolf Jaenisch
Journal:  Cell       Date:  2011-07-14       Impact factor: 41.582

4.  High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors.

Authors:  Hilda Petrs-Silva; Astra Dinculescu; Qiuhong Li; Seok-Hong Min; Vince Chiodo; Ji-Jing Pang; Li Zhong; Sergei Zolotukhin; Arun Srivastava; Alfred S Lewin; William W Hauswirth
Journal:  Mol Ther       Date:  2008-12-16       Impact factor: 11.454

5.  Highly efficient endogenous human gene correction using designed zinc-finger nucleases.

Authors:  Fyodor D Urnov; Jeffrey C Miller; Ya-Li Lee; Christian M Beausejour; Jeremy M Rock; Sheldon Augustus; Andrew C Jamieson; Matthew H Porteus; Philip D Gregory; Michael C Holmes
Journal:  Nature       Date:  2005-04-03       Impact factor: 49.962

6.  Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo.

Authors:  Anusara Daenthanasanmak; Gustavo Salguero; Sylvia Borchers; Constanca Figueiredo; Roland Jacobs; Bala Sai Sundarasetty; Andreas Schneider; Axel Schambach; Britta Eiz-Vesper; Rainer Blasczyk; Eva M Weissinger; Arnold Ganser; Renata Stripecke
Journal:  Vaccine       Date:  2012-06-09       Impact factor: 3.641

7.  A dual role of EGFR protein tyrosine kinase signaling in ubiquitination of AAV2 capsids and viral second-strand DNA synthesis.

Authors:  Li Zhong; Weihong Zhao; Jianqing Wu; Baozheng Li; Sergei Zolotukhin; Lakshmanan Govindasamy; Mavis Agbandje-McKenna; Arun Srivastava
Journal:  Mol Ther       Date:  2007-04-17       Impact factor: 11.454

8.  Genetic engineering of human pluripotent cells using TALE nucleases.

Authors:  Dirk Hockemeyer; Haoyi Wang; Samira Kiani; Christine S Lai; Qing Gao; John P Cassady; Gregory J Cost; Lei Zhang; Yolanda Santiago; Jeffrey C Miller; Bryan Zeitler; Jennifer M Cherone; Xiangdong Meng; Sarah J Hinkley; Edward J Rebar; Philip D Gregory; Fyodor D Urnov; Rudolf Jaenisch
Journal:  Nat Biotechnol       Date:  2011-07-07       Impact factor: 54.908

9.  A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity.

Authors:  Claudio Mussolino; Robert Morbitzer; Fabienne Lütge; Nadine Dannemann; Thomas Lahaye; Toni Cathomen
Journal:  Nucleic Acids Res       Date:  2011-08-03       Impact factor: 16.971

10.  A novel strategy for the negative selection in mouse embryonic stem cells operated with immunotoxin-mediated cell targeting.

Authors:  K Kobayashi; T Ohye; I Pastan; T Nagatsu
Journal:  Nucleic Acids Res       Date:  1996-09-15       Impact factor: 19.160

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.